HLA-B27 rats develop osteopaenia through increased bone resorption without any change in bone formation

Area of Science:

• Bone Biology
• Inflammatory Bowel Disease Research
• Animal Models of Disease

Background:

• Osteopenia is a frequent complication of inflammatory bowel diseases (IBD), but the underlying mechanisms of bone loss remain unclear.
• Investigating bone loss in a relevant animal model is crucial for understanding IBD-associated skeletal complications.

Purpose of the Study:

• To investigate bone loss in HLA-B27 transgenic rats, a model of spontaneous colitis.
• To compare bone remodeling markers and direct bone protein synthesis measurements.
• To elucidate the role of systemic inflammation in IBD-related bone fragility.

Main Methods:

• Evaluated systemic inflammation in HLA-B27 transgenic rats and control rats (18-27 months).
• Measured bone mineral density, femoral failure load, and biochemical markers of bone remodeling.
• Assessed fractional protein synthesis rate in tibial epiphysis and urinary deoxypyridinoline excretion.

Main Results:

• HLA-B27 rats exhibited lower bone mineral density compared to controls.
• Urinary deoxypyridinoline excretion, a marker of bone resorption, was significantly increased in HLA-B27 rats.
• Plasma osteocalcin (bone formation marker) and tibial protein synthesis did not differ between groups.

Conclusions:

• Bone fragility in HLA-B27 rats is primarily driven by increased bone resorption.
• Systemic inflammation associated with IBD likely disrupts bone remodeling homeostasis.
• These findings provide insights into the pathogenesis of osteopenia in human IBD.